Repositorio Dspace

Listar por autor "Abad, Etna"

Listar por autor "Abad, Etna"

Ordenar por:Orden:Resultados:

  • PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity 
    Martínez-Bosch, Neus; Manero-RuPérez, Noemi; Vázquez-Bellon, Nuria; Nickell-Hernández, Bennett; Ventura-Blanch, Cristina; Lutfi, Nura; Lechuga, Carmen-G; Martínez, Carlos; Moreno, Mireia; Ampurdanes, Coral; Abad, Etna; Iglesias, Mar; Muñoz-Escribano, María; Janic, Ana; Rovira, Meritxell; Guerra, Carmen; Rabinovich, Gabriel-A; Yelamos, José; Navarro, Pilar (AMER ASSOC ADVANCEMENT SCIENCE, 2026-05-08)
    Pancreatic cancer represents one of the most lethal tumors, characterized by an immunosuppressive microenvironment and a lack of cytotoxic immune cell infiltrates, which confer resistance to immunotherapy. Here, we demonstrate ...
  • The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability 
    Abad, Etna; Sandoz, Jeremy; Romero, Gerard; Zadra, Ivan; Urgel-Solas, Julia; Borredat, Pablo; Kourtis, Savvas; Ortet, Laura; Martínez, Carlos-M; Weghorn, Donate; Sdelci, Sara; Janic, Ana (BMC, 2024-04-29)
    BACKGROUND: TP53, the most frequently mutated gene in human cancers, orchestrates a complex transcriptional program crucial for cancer prevention. While certain TP53-dependent genes have been extensively studied, others, ...